(4R)-4-((3S,9R,10S,13R,14R,17R)-10,13-Dimethyl-3-((tetrahydro-2H-pyran-2-yl)oxy)-2,3,4,5,6,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic Acid

Ref. TR-H723445

Informations sur le produit

• Nom: (4R)-4-((3S,9R,10S,13R,14R,17R)-10,13-Dimethyl-3-((tetrahydro-2H-pyran-2-yl)oxy)-2,3,4,5,6,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic Acid

Description

Applications (4R)-4-((3S,9R,10S,13R,14R,17R)-10,13-Dimethyl-3-((tetrahydro-2H-pyran-2-yl)oxy)-2,3,4,5,6,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic Acid is an intermediate in the synthesis of 5α-Cholesta-7,24-diene-3β-ol (C431505), which is the derivative of Zymosterol (Z701520). It can also be used for identification of a new plasma biomarker of Alzheimer's disease using metabolomics technology.
References Sato, Y., et al.: J. Lipid Res., 53, 567 (2012); Schoenheimer, et al.: J. Biol. Chem., 105, 355 (1934);

• Marque: TRC

Propriétés chimiques

• Masse moléculaire: 458.673
• Formule: C₂₉H₄₆O₄
• Couleur/Forme: Yellow Solid
• InChI: InChI=1S/C29H46O4/c1-19(7-12-26(30)31)23-10-11-24-22-9-8-20-18-21(33-27-6-4-5-17-32-27)13-15-28(20,2)25(22)14-16-29(23,24)3/h9,19-21,23-25,27H,4-8,10-18H2,1-3H3,(H,30,31)/t19-,20?,21+,23-,24+,25+,27?,28+,29-/m1/s1
• Code InChI: InChIKey=DWGCMWWWHJRLHG-KVAWYWAASA-N
• SMILES: C[C@H](CCC(=O)O)[C@H]1CC[C@H]2C3=CCC4C[C@@H](OC5CCCCO5)CC[C@]4(C)[C@H]3CC[C@@]21C